Arrowhead Research (ARWR) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $82.00 +0.22%
Revenue Growth %: +89.5%
Financial Fact:
REVENUE: 39.58K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +89.5%
Financial Fact:
REVENUE: 39.58K
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Arrowhead Research (NASDAQ: ARWR) reported Q2 EPS of ($0.35), $0.02 better than the analyst estimate of ($0.37).
For earnings history and earnings-related data on Arrowhead Research (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)
- EU approves Arrowhead's plozasiran for rare triglyceride disorder
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
